University of Illinois Urbana-Champaign

The CRISPR-Cas9 Patent Appeal: Where Do We Go From Here?

Sherkow, Jacob S.

Permalink

https://hdl.handle.net/2142/110368

Description

Title
The CRISPR-Cas9 Patent Appeal: Where Do We Go From Here?
Author(s)
Sherkow, Jacob S.
Issue Date
2018-10-23
Keyword(s)
  • crispr
  • patent
  • appeal
  • interference
  • doudna
  • zhang
  • broad institute
  • berkeley
Abstract
An appellate court in the United States affirmed the Patent Office's finding that the Broad Institute's patents covering eukaryotic applications of CRISPR-Cas9 was separately patentable over the University of California's (UC) earlier patent application. This does not bode well for future negotiations between UC and the Broad Institute, even as nuclease technology continues to eclipse the original dispute. This perspective explores the appellate decision, where UC goes from here, and what this all means for scientists in the future.
Publisher
The CRISPR Journal
Type of Resource
text
Language
en
Permalink
http://hdl.handle.net/2142/110368
DOI
10.1089/crispr.2018.0044

Owning Collections

Illinois Research and Scholarship (Open Collection) PRIMARY
This is the default collection for all research and scholarship developed by faculty, staff, or students at the University of Illinois at Urbana-Champaign